.png)
Long COVID Gut Microbiome Risk Test
What is Long COVID Gut Microbiome Risk Test?
​Our invention relates to the first in the world discovery to characterize unique microbial signatures in post-acute COVID syndrome (PACS). We have developed a novel, noninvasive stool test using multi-kingdom analyses to help differentiate PACS with high predictive values (AUC 0.98). It offers hope for intervention through microbiome modulation for the millions of people suffering from debilitating Long COVID symptoms.
Unmet Need
-
Cause of Post Acute COVID-19 Syndrome ("Long COVID") is unclear

-
We found over 70% people have "Long COVID" after SARS-Cov-2 infection

-
"Long COVID" can affect >10 organs with >49 symptoms
-
Most common symptoms are fatigue, poor memory and hair loss
-
There is a lack of diagnosis or prediction tool for "Long COVID"
Our Solution
-
World’s first stool test to predict long COVID symptoms for multi-organsusing artificial intelligence → Personalized Management
-
Sensitivity of 95% and Specificity of 97%
​
​
​
​​​
-
Non-invasive, accurate, fast and convenient
